UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

 

March 14, 2014

 


   

TEARLAB CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-51030

 

59-343-4771

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

9980 Huennekens Street, Suite 100

San Diego, CA 92121

(Address of principal executive offices, including zip code)

 

(858) 455-6006

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))  

 



 
 

 

 

Item 1.01.      Entry into a Material Definitive Agreement

 

On March 14 , 2014, TearLab Corporation (the “Company”) through its wholly-owned subsidiary, OccuLogix LLC, (the “Sub”) entered into an asset purchase agreement (the “Purchase Agreement”) with AOAExcel, Inc. (“AOA”) and, in connection with the Purchase Agreement, consummated the purchase from AOA of assets specifically related to AOA’s cloud-based, single sign-on portal technology used to secure connectivity between doctors, patients, institutions and payers (the “OcuHub Business”) (the “Transaction”).

 

Pursuant to the Purchase Agreement, as consideration for such purchase by the Sub from AOA: (a) the Sub paid AOA $1,400,000 in cash at the closing, and (b) each of the Company and the Sub will be obligated to offer a fifteen percent (15%) discount off of the lowest price offered by the Sub to the general population with respect to the OcuHub Platform, OcuHub Direct and OcuHub Image products and services for a period of ten (10) years following the date on which OcuHub Services are first offered to members of the American Optometric Association.

 

The Purchase Agreement also includes customary representations, warranties, covenants and indemnification obligations of the parties agreed to by each of the Company and the Sub in the Purchase Agreement.

 

The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the complete text of the Purchase Agreement, which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.

 

Item 5.02.      Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain

                        Officers.

           

In connection with the Transaction, the Company entered into an offer letter with Barry Barresi, pursuant to which Dr. Barresi will become the Chief Executive Officer of the Sub (the “Offer Letter”).

           

On February 28, 2014 , the Company entered into the Offer Letter with Dr. Barresi pursuant to which Dr. Barresi will earn an annual base salary of $250,000. Upon the closing of the Transaction, Dr. Barresi earned a bonus of $35,000 which is due within ten (10) business days after the commencement of his employment with the Company. He is eligible to receive 25% of his salary as an annual bonus which will be prorated from his date of hire during the first year of employment based on the number of calendar days Dr. Barresi is employed.  This bonus plan or arrangement has been established by the Company’s Board of Directors in its sole discretion.  In no event will any bonus be payable to Dr. Barresi later than March 15 of the calendar year following the calendar year in which the bonus is earned. The Company will also cover relocation costs up to $15,000.

 

Dr. Barresi previously served as the Executive Director of American Optometric Association from June 2008 to February 2014. Prior to that, Dr. Barresi previously held various executive positions at the New England Eye Institute Inc., State University of New York and Partner Provider Health Inc.

           

The foregoing description of the Offer Letter does not purport to be complete and is qualified in its entirety by reference to the complete text of the Offer Letter, which is filed as Exhibit 10.2 hereto and is incorporated herein by reference.

 

Item 8.01.     Other Events.

 

The Company issued a release on March 14, 2014 announcing the transactions contemplated by the Purchase Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

 

Item 9.01.      Financial Statements and Exhibits.

 

(d)  Exhibits.

  

Exhibit No.

 

Description

     

10.1

 

Asset Purchase Agreement, dated as of March 14, 2014, by and among AOAExcel, Inc., OccuLogix LLC and TearLab Corporation.

10.2

 

Offer letter, dated February 28, 2014 by and between Barry Barresi and TearLab Corporation. 

99.1

 

Press Release of TearLab Corporation dated March 14, 2014.

   

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

   

TEARLAB CORPORATION

     
 

By:

/s/ William G. Dumencu

 
   

William G. Dumencu

Chief Financial Officer

 

Date: March 17, 2014

 

 
 

 

   

INDEX

 

Exhibit No.

 

Description of Exhibit

     

10.1

 

Asset Purchase Agreement, dated as of March 14, 2014, by and among AOAExcel, Inc., OccuLogix LLC and TearLab Corporation.

10.2

 

Offer letter, dated February 28, 2014 by and between Barry Barresi and TearLab Corporation.

99.1

 

Press Release of TearLab Corporation, March 14, 2014.

 

 

Exhibit 10.1

 

ASSET PURCHASE AGREEMENT

 

THIS ASSET PURCHASE AGREEMENT (this “ Agreement ”), is made as of this 14 th day of March 2014, by and among:

 

AOAExcel, Inc., a Delaware corporation, with offices at 243 North Lindbergh Boulevard, St. Louis, MO 63141 (“ Seller ”);

 

a n d

 

OccuLogix LLC, a Delaware limited liability company, a wholly-owned subsidiary of TearLab Corporation, with offices at 9980 Huennekens Street, Suite 100, San Diego, CA 92122 (“ Buyer ”), and TearLab Corporation, a Delaware corporation, with offices at 9980 Huennekens Street, Suite 100, San Diego, CA 92122 (“ Parent ”).

 

W I T N E S S E T H:

 

WHEREAS, Seller owns certain assets and has certain contractual and business relationships which it currently uses in connection with its OcuHub business consisting of developing and attempting to commercialize the OcuHub technology platform designed to connect and coordinate collaboration and clinical integration within the eye care market (the “ Business ”);

 

WHEREAS, Seller desires to sell, and Buyer desires to purchase certain assets of Seller utilized solely in the Business, and to assume certain specified Business liabilities of Seller, as of the Closing Date (as defined herein) for the consideration and upon the terms and conditions set forth in this Agreement;

 

WHEREAS, in connection with the transactions contemplated by this Agreement, Buyer, Seller and Parent shall enter into a Marketing Agreement (as defined herein) pursuant to which Seller will provide certain marketing support for Buyer with respect to the Business.

 

NOW, THEREFORE, in consideration of the premises and the mutual representations, warranties, covenants and agreements herein contained for good and valuable consideration, the parties hereto, intending to be legally bound, agree as follows:

 

ARTICLE I

PURCHASE AND SALE OF ASSETS

 

1.1      Purchased Assets . Subject to the terms and conditions hereof, at the Closing (as defined herein), Seller shall assign, convey, sell, and/or transfer to Buyer, and Buyer shall purchase or be assigned all of Seller’s rights in and to the following described assets currently used in connection with the Business (collectively, the “ Purchased Assets ”):

 

(a)     the following Business services, as currently in existence and which are in different stages of development (collectively, the “ OcuHub Services ”): (i) the “ OcuHub Platform ” which is a web-based Platform as a Service (“ PaaS ”); (ii) the “ OcuHub Direct ” application or functionality; and (iii) the cloud based “ OcuHub Image ” application or functionality;

 

(b)     all of Seller’s tangible and intangible work product associated solely with the design and development of the OcuHub Services, including, without limitation, operating instructions and maintenance manuals, marketing materials, and other tangible or intangible materials that are used in or held for use solely in connection with OcuHub Services;

 

 
 

 

   

(c)     three (3) Dell MiiM Servers (together with any installed software, to the extent assignable), and certain Polycom digital phones, model Soundpoint IP335;

 

(d)     all of Seller’s trade names, trademarks, trade dress, copyrights and other intellectual property used solely in the Business, to the extent assignable, including without limitation, the Application of Intent to Use the Service Mark “OcuHub” (US Serial Number 85972258), and to the extent assignable, the domain names Ocuhubportal.com, Ocuhubportal.net, Ocuhubportal.org, Ocuhubhealth.com, Ocuhubhealth.net, and Ocuhubhealth.org; and

 

(e)     all written agreements, contracts, commitments, undertakings, licenses or arrangements relating solely to the Business and identified on Schedule 1.1(e) attached hereto, to the extent assignable (the “ Assigned Contracts ”).

 

1.2      Assets Excluded from Purchase . Other than the Purchased Assets, no other asset of Seller shall be transferred and sold to Buyer pursuant to this Agreement, including, without limitation, all rights that accrue or will accrue to Seller under this Agreement.

 

ARTICLE II

CONSIDERATION

 

2.1      Consideration .

 

(a)      Closing Cash Consideration . Buyer agrees to pay Seller cash in the amount of One Million Four Hundred Thousand Dollars ($1,400,000) at Closing (the “ Initial Consideration ”).

 

(b)      Additional Consideration . As additional consideration for the Purchased Assets, Buyer and Parent covenant and agree that for a period of ten (10) years following the date on which OcuHub Services are first offered to members of the American Optometric Association (“ AOA ”), each AOA member shall receive a fifteen percent (15%) discount off of the lowest price offered by Buyer to the general population with respect to the OcuHub Platform, OcuHub Direct and OcuHub Image products and services (the “ Additional Consideration ”). In the event Buyer offers a lower price at any time to members of any other professional association, then members of the AOA will receive such lower price on a go forward basis only, effective immediately upon the next billing cycle. Such lower price shall not be applied to any prior period and AOA members shall not be entitled to any refund, rebate or other adjustment with respect to any prior period.

 

2.2      Assumption of Liabilities . Buyer and Parent, jointly and severally, covenant and agree to assume and be responsible for all of the following liabilities and obligations of Seller, whether known or unknown, liquidated or unliquidated, asserted or unasserted, absolute or contingent, accrued or unaccrued or otherwise, and whether due or to become due (collectively, the “ Assumed Liabilities ”), each of which Buyer and Parent jointly and severally covenant and agree to pay, perform and discharge, when due, in the ordinary course of business:

 

(a)     any and all liabilities and obligations arising pursuant to or under any of the Assigned Contracts;

 

 
2

 

   

(b)     any and all liabilities and obligations incurred or arising after the Closing Date with respect to the Purchased Assets and/or the Business; and

 

(c)     any and all liabilities and obligations identified on Schedule 2.2(c) attached hereto.

 

2.3      Liabilities Not Assumed . Except with respect to the Assumed Liabilities or as otherwise expressly provided in this Agreement, Buyer shall not, by virtue of its purchase of the Purchased Assets or otherwise, directly or indirectly, assume or become responsible for any liability or obligation of Seller or of any affiliate of Seller of any nature whatsoever, whether liquidated or unliquidated, known or unknown, actual or inchoate, accrued, contingent or otherwise, including without limitation, any income taxes imposed upon Seller as a result of the Closing, any liability arising from Seller’s non-compliance with any applicable foreign, federal, state and local laws, rules, regulations and ordinances respecting employment, employment practices, the terms and conditions of employment, employee safety and wages and hours, or worker classification.

 

2.4      Allocation of Consideration . The parties agree that the Initial Consideration shall be allocated, for tax purposes, among the Purchased Assets in a manner consistent with the provisions of Section 1060 of the Internal Revenue Code (the “ Code ”) and all regulations promulgated thereunder. Buyer and Seller shall endeavor to agree to the form of IRS Form 8594 for inclusion with the federal income tax return of Seller ending on the Closing Date and any similar allocation required under state or local law (collectively, “ IRS Form 8594 ”). If agreement is reached with respect to an allocation, Seller and Buyer agree to report the transactions contemplated by this Agreement for federal tax purposes on IRS Form 8594 in accordance with such allocation, and shall not take any position or action inconsistent therewith upon examination of any tax return, in any refund claim, in any litigation, investigation or otherwise; provided, however, that if, in any audit of any tax return of Seller or Buyer by a governmental authority, the fair market values are finally determined to be different from IRS Form 8594, as adjusted, Buyer and Seller may (but shall not be obligated to) take any position or action consistent with the fair market values as finally determined in such audit.

   

 
3

 

 

ARTICLE III

OTHER AGREEMENTS; CLOSING

 

3.1      Marketing Agreement . Incident to Closing, Seller and Buyer are entering into a Marketing Agreement (the “ Marketing Agreement ”) pursuant to which, among other things, Seller will provide certain marketing services for Buyer with respect to the OcuHub Services.

 

3.2      Support Agreement . Incident to Closing, Seller and Buyer are entering into a Support Agreement (“ Support Agreement ”) pursuant to which Seller agrees, for a period not to exceed beyond May 31, 2014, to provide certain administrative and information technology support services to Buyer with respect to the Business.

 

3.3      Employees . Buyer has had, and shall have, the right to hire any or all of the employees set forth on Schedule 3.3 (the “ Designated Employees ”). Seller has terminated, or shall terminate at Closing, each of the Designated Employees, and Seller shall be responsible for any and all compensation and benefits owing by Seller to any such Designated Employees for any period during which said Designated Employees were employed by Seller. Buyer shall be responsible for any and all compensation and benefits owing to any such Designated Employees who are hired by Buyer for the period from and after Closing.

 

3.4      Closing . The closing of the purchase and sale of the transactions contemplated by this Agreement (the “ Closing ”) shall take place incident to the execution and delivery of this Agreement (the “ Closing Date ”).

 

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF SELLER

 

As of the date hereof, Seller hereby represents and warrants to Buyer as follows:

 

4.1      Organization and Good Standing . Seller is a corporation validly existing and in good standing under the laws of the state in which it is incorporated and has the power and authority to carry on the Business as presently conducted, to own the assets which it owns and to perform its obligations hereunder. Seller is duly qualified and in good standing in each jurisdiction where the character of its properties owned or leased or the nature of its activities makes such qualification necessary, except where the failure to be so qualified would not have a material adverse effect on Seller.

 

4.2      Power and Authorization . Seller has full legal right, power and authority to enter into and perform its obligations under this Agreement and under the other agreements and documents required to be delivered by it at Closing (the “ Seller Transaction Documents ”). This Agreement has been duly and validly executed and delivered by Seller and constitutes the legal, valid and binding obligation of Seller enforceable against it in accordance with its terms; except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting creditors’ rights generally and by the availability of equitable remedies.

 

4.3      No Conflicts . The execution, delivery and performance of this Agreement and the Seller Transaction Documents by Seller do not and will not (with or without the passage of time or the giving of notice), violate or conflict with the organizational documents of Seller.

 

 
4

 

   

4.4      Title . Seller currently has, and upon transfer of the Purchased Assets to Buyer at Closing as contemplated by this Agreement Buyer shall acquire, good and marketable title to the Purchased Assets free and clear of any encumbrances

 

4.5      Brokers . Except for The Fortune Group, no person acting on behalf of Seller or any of its affiliates or under the authority of any of the foregoing is or will be entitled to any broker’s or finder’s fee or any other commission or similar fee, directly or indirectly, from any of such parties in connection with any of the transactions contemplated by this Agreement.

 

4.6      Material Assets . To Seller’s Knowledge, the Purchased Assets include all material tangible and intangible assets and rights that are used in the operation or conduct of the Business, except for those items set forth on Schedule 4.6 attached hereto.

 

4.7      Compliance with Laws . To Seller’s Knowledge, Seller is in compliance with all applicable laws, and Seller has not received any written notice from any governmental agency or instrumentality of any violation of or failure to comply with any law except such notices that would not in the aggregate result in a Material adverse effect on Seller’s Business.

 

4.8      Litigation . To Seller’s Knowledge, there are no suits or proceedings (arbitration or otherwise) involving or affecting Seller, the Business or the Purchased Assets, pending or threatened, before or by any court or governmental agency or instrumentality, or before an arbitrator of any kind, at law or in equity.

 

4.9      Contracts . To Seller’s Knowledge, Schedule 1.1(e) attached hereto sets forth a list, as of the date of this Agreement, of all Material contracts involving the Business.

 

4.10      Solvency . No transfer of property is being made by Seller in connection with the transactions contemplated by this Agreement with the intent to hinder, delay or defraud either present or future creditors of Seller. Seller believes that the consideration to be received under this Agreement reflects a fair price for the Purchased Assets under current circumstances. This Agreement is the result of arm’s length negotiations between Seller and Buyer.

 

4.11      Taxes . To Seller’s Knowledge, all federal, state and local tax returns and reports required to be filed by Seller relating to the Purchased Assets or the Business have been duly filed, and all federal, state and local income, franchise, sales, use, payroll, property and other taxes (including interest and penalties) (collectively, “ Taxes ”) due from Seller as reflected on such returns have been duly paid, except for those being contested in good faith or for which adequate reserves have been taken; and except where a failure to do so would not have a Material adverse effect on Seller.

 

ARTICLE V

REPRESENTATIONS AND WARRANTIES OF BUYER AND PARENT

 

Buyer and Parent hereby jointly and severally represent and warrant to Seller as follows:

 

5.1      Organization and Good Standing . Buyer is a limited liability company duly organized, validly subsisting and in good standing under the laws of the state in which it is formed, and Buyer has all the requisite power and authority as a limited liability company to carry on its business as presently conducted, to own and lease the assets which it owns and leases and to perform its obligations hereunder. Parent is a business corporation duly organized, validly subsisting and in good standing under the laws of the state in which it is incorporated and Parent has all the requisite power and authority as a corporation to carry on its business as presently conducted, to own and lease the assets which it owns and leases and to perform its obligations hereunder. Buyer is a wholly-owned subsidiary of Parent.

 

 
5

 

   

5.2      Power and Authorization . Buyer and Parent each have the full legal right, power and authority to enter into and perform its respective obligations under this Agreement and under the other agreements and documents required to be delivered by them prior at Closing (the “ Buyer Transaction Documents ”). The execution, delivery and performance by Buyer and Parent of this Agreement and the Buyer Transaction Documents have been duly authorized by all necessary action. Each of the Buyer Transaction Documents has been duly and validly executed and delivered by Buyer and Parent (as applicable), and constitutes the legal, valid and binding obligation of Buyer and Parent, enforceable against each of them in accordance with its terms; except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting creditors’ rights generally and by the availability of equitable remedies.

 

5.3      No Conflicts . The execution, delivery and performance of this Agreement and the Buyer Transaction Documents by Buyer and Parent do not and will not (with or without the passage of time or the giving of notice), violate or conflict with the organizational documents of either Buyer or Parent, or any material agreement to which either Buyer or Parent is a party or by which either is bound.

 

5.4      Brokers . No person or entity acting on behalf of Buyer, Parent or any of their respective affiliates or under the authority of any of the foregoing, is or will be entitled to any broker’s or finder’s fee or any other commission or similar fee, directly or indirectly, from any of such parties in connection with any of the transactions contemplated by this Agreement .

 

5.5      Informed and Sophisticated Purchaser . Buyer and Parent have been provided sufficient access to the assets, facilities, and information of Seller to be able to make an informed decision with respect to this transaction and to the Business. Buyer and Parent acknowledge and agree that the Business and the OcuHub Services are in the development stages and that no representations, warranties or guaranties of any kind are being given by Seller with respect to the successful or ongoing operation or commercialization of the Business.

 

ARTICLE VI

CLOSING DELIVERABLES

 

6.1      Closing Deliverables of Seller . At the Closing, Seller shall deliver, or cause to be delivered, to Buyer the following:

 

(a)     a bill of sale, assignment and assumption agreement duly executed by Seller (the “ Bill of Sale, Assignment and Assumption Agreement ”), substantially in the form of Attachment A attached hereto;

 

(b)     counterparts of the Marketing Agreement and the Support Agreement, each duly executed by Seller;

 

(c)     an assignment of Seller’s Application of Intent to Use the Service Mark “OcuHub” (US Serial Number 85972258);

 

(d)     a certificate of good standing of a recent date for Seller in the State of Missouri; and

 

 
6

 

   

(e)     a copy of the resolutions of the Board of Directors, if necessary, authorizing the execution, delivery and performance of this Agreement and the Seller Transaction Documents, certified as of the Closing Date by an officer of Seller.

 

6.2      Closing Deliverables of Buyer . At the Closing, Buyer and Parent shall deliver, or cause to be delivered, to Seller the following:

 

(a)     the Initial Consideration, by wire transfer of immediately available funds as directed by Seller;

 

(b)     the Bill of Sale, Assignment and Assumption Agreement, executed by Buyer and Parent;

 

(c)     counterparts of the Marketing Agreement and the Support Agreement, each duly executed by Buyer and Parent; and

 

(d)     a copy of the resolutions, if necessary, of the board of directors of each of Buyer and Parent authorizing the execution, delivery and performance by Buyer and Parent of this Agreement and the Buyer Transaction Documents, certified as of the Closing by an officer of Buyer and Parent, as applicable.

 

ARTICLE VII

POST-CLOSING COVENANTS

 

7.1      Further Assurances . Subject to the terms and conditions herein provided, from time to time after the Closing, without further consideration, the parties shall cooperate with each other and shall use commercially reasonable efforts to take or cause to be taken all such further actions, and to do, cause to be done, all things necessary, proper and advisable under applicable laws and regulations, to consummate and make effective the transactions provided for in this Agreement, including, without limitation, (a) the execution and delivery of instruments of transfer or assignment or assumption, or such other documents to the other party or parties, as such other party or parties reasonably may request to evidence or perfect Buyer’s right, title and interest to the Purchased Assets or to more effectively relieve Seller of any liabilities or obligations assumed by Buyer and Parent hereunder, and (b) to the extent any documents required to be delivered at Closing were not delivered, the (post-Closing) satisfaction of such conditions and the delivery of such documents.

 

7.2      Consents . To the extent any of the approvals, consents or waivers required to consummate the transactions contemplated by this Agreement, including, without limitation, the consents and approvals required to assign any of the Assigned Contracts to Buyer, have not been obtained by Seller as of the Closing Date, Seller shall use its commercially reasonable efforts to do the following:

 

(a)     cooperate with Buyer in any reasonable and lawful arrangements designed to provide the benefits of such Assigned Contracts to Buyer as long as Buyer and/or Parent promptly reimburses Seller for all costs and expenses incurred by Seller in connection therewith; and

 

(b)     enforce, at the request of Buyer and at the expense and for the account of Buyer, any and all rights of Seller arising from such interest against the other party or parties thereto (including the right to elect to terminate such interest in accordance with the terms thereof upon the written advice of Buyer).

 

 

 
7

 

 

ARTICLE VIII

INDEMNIFICATION

 

8.1      Survival of Representations and Warranties .

 

(a)      All representations and warranties of Seller, Buyer and Parent contained respectively in Article IV or Article V shall survive the Closing until the eighteen (18) month anniversary of the Closing Date (the “ Survival Date ”); provided, however, that any good faith claim for indemnification based upon a breach of any such representation or warranty and asserted prior to the Survival Date by written notice in accordance with Section 9.3 shall survive until final resolution of such claim.

 

(b)      The respective covenants, agreements and obligations of Seller, Buyer and Parent set forth in this Agreement shall survive the execution and delivery of this Agreement, and the Closing Date in accordance with their respective terms.

 

8.2      Indemnification by Seller .

 

(a)     Subject to the limitations set forth in this Article VIII , following the Closing Date, Seller shall indemnify, defend and hold harmless Buyer, Parent, and their respective successors, permitted assigns, officers, directors, employees and agents (each, an “ Indemnified Person ” or the “ Buyer Indemnitees ”) from and against any and all Damages (as defined herein), whether or not involving a third-party claim, including reasonable attorneys’ fees (collectively, “ Buyer Damages ”), to the extent arising out of, relating to or resulting from: (i) the failure of any representation or warranty of Seller contained in Article IV to be true and correct in all material respects; (ii) the failure of Seller to fulfill any of its obligations under this Agreement, and/or (iii) the operation of the Business prior to Closing.

 

(b)       For purposes of this Article VIII , “ Damages ” shall mean and include any loss, damage, injury, liability, claim, demand, judgment, award, fine, penalty, (including reasonable legal fees), charge, cost or expense of any nature; provided however, “ Damages ” shall not include any special, indirect, consequential or punitive damages.

 

8.3      Indemnification by Buyer . Subject to the terms and conditions of this Article VIII , following the Closing Date, Buyer and Parent shall jointly and severally indemnify, defend and hold harmless Seller, AOA and their respective successors, assigns, officers, directors, employees and agents (each, also an “ Indemnified Person ” or the “ Seller Indemnitees ”) from and against any and all Damages whether or not involving a third-party claim, including reasonable attorneys’ fees, to the extent arising out of, relating to or resulting from: (i) the failure of any representation or warranty of Buyer or Parent contained in Article V to be true and correct in all material respects; (ii) the failure of Buyer or Parent to fulfill any of its respective obligations under this Agreement, including without limitation, fulfillment of all Assumed Liabilities in a timely manner, and/or (iii) the operation of the Business from and after Closing.:

 

8.4      Exclusive Remedy . Recovery from an indemnifying party pursuant to this Article VIII shall be the sole and exclusive remedy of the Buyer Indemnitees or Seller Indemnitees for all Damages for which they are entitled to be indemnified (the “ Indemnification Obligations ”), or under any other theory of liability in contract, tort, equity or otherwise arising out of, in connection with or related to this Agreement.

 

 
8

 

 

 

8.5      Procedure for Indemnification .

 

(a)      Claims . Promptly after becoming aware of any Damages for which an Indemnified Person is entitled to be indemnified pursuant to Section 8.2 or Section 8.3 (but in no event later than the Survival Date), an Indemnified Person shall deliver to the indemnifying party a certificate signed by an appropriately authorized officer of the Indemnified Person (a “ Claim Certificate ”), (i) stating the aggregate amount of Damages or an estimate thereof, in each case to the extent known or reasonably determinable at such time and (ii) specifying in reasonable detail the individual items of such Damages included in the amount so stated, the date each such item was paid or properly accrued or arose, and the nature of the misrepresentation, breach or claim and the section under this Agreement pursuant to which such item is related; provided, however , that no delay on the part of an Indemnified Person in notifying an indemnifying party shall relieve the indemnifying party of any liability or obligations hereunder, except to the extent that said notice is given after the Survival Date or an indemnifying party has been prejudiced thereby, and then only to such extent. In the absence of any objections to such Claim Certificate as provided in Section 8.5(b) by the date set forth in Section 8.5(b) , an Indemnified Person shall, subject to the other provisions of this Agreement, be entitled to recover from an indemnifying party the amount of such Damages in satisfaction of the Indemnification Obligations.

 

(b)      Objection to Claim Certificate . An indemnifying party shall have thirty (30) days after delivery to it of a Claim Certificate to deliver to an Indemnified Person a written response to such Claim Certificate (a “ Claim Response ”). If after such thirty (30) day period an indemnifying party has not delivered a Claim Response to an Indemnified Person or it has delivered a Claim Response which does not dispute any portion of the claims contained in the Claim Certificate, the Indemnification Obligations in the amount specified in the Claim Certificate shall become final. If the Claim Response disputes any claims contained in the Claim Certificate, the indemnifying party and the Indemnified Person shall attempt in good faith for an additional thirty (30) days to agree upon the rights of the respective parties with respect to each of such claims. If the indemnifying party and the Indemnified Person should so agree, a certificate setting forth such agreement shall be prepared and signed by both parties. If no such agreement can be reached after good faith negotiations, either the indemnifying party or the Indemnified Person may pursue its rights and remedies hereunder in a court of law.

 

(c)      Third-Party Claims . Promptly after the assertion by any third party of any claim against any Indemnified Person (a “ Third-Party Claim ”) that, in the judgment of such Indemnified Person, may result in the incurrence by such Indemnified Person of Damages for which such Indemnified Person would be entitled to indemnification pursuant to this Agreement, such Indemnified Person shall deliver to the indemnifying party a written notice describing in reasonable detail such Third-Party Claim; provided, however , that no delay on the part of the Indemnified Person in notifying the indemnifying party shall relieve the indemnifying party of any liability or obligations hereunder, except to the extent that said notice is given after the Survival Date or the indemnifying party has been prejudiced thereby, and then only to such extent. The indemnifying party shall have the right, but not the obligation, exercisable in its sole discretion by written notice to the Indemnified Person within thirty (30) days of receipt of notice from the Indemnified Person of the commencement of or assertion of any Third-Party Claim, to assume the defense and control the settlement of such Third-Party Claim. The Indemnified Person shall have the right to participate in (but not control), at its own expense, the defense and settlement of any Third-Party Claim. If the indemnifying party does not elect to undertake and conduct the defense of a Third-Party Claim, the Indemnified Person shall undertake the defense of such Third-Party Claim. In the event the indemnifying party has assumed the defense of any Third-Party Claim, the indemnifying party shall not consent to a settlement of, or the entry of any judgment arising from, any such Third-Party Claim without the Indemnified Person’s prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed), unless such settlement or judgment relates solely to monetary damages and provides for a complete release of the Indemnified Person, in which case, no such consent shall be required. The Indemnified Person shall have the right to settle, or consent to the entry of any judgment arising from, any Third-Party Claim for which the indemnifying party has not assumed the defense, but such settlement or consent shall not be binding on the indemnifying party if such settlement or consent was without such indemnifying party’s consent (such consent not to be unreasonably withheld, conditioned, or delayed). Whether or not the indemnifying party elects to defend or prosecute any Third-Party Claim, both parties hereto shall cooperate in the defense or prosecution thereof and shall furnish such records, information and testimony, and attend such conferences, discovery proceedings, hearings, trials and appeals, as may be reasonably requested in connection therewith.

 

 
9

 

   

8.6      Limitations on Indemnification . Notwithstanding anything herein to the contrary, (a) Seller shall have no obligation to indemnify the Buyer Indemnitees with respect to Buyer Damages arising under Section 8.2 unless and until the aggregate amount of all Buyer Damages thereunder exceeds Twenty-Five Thousand and 00/100 Dollars ($25,000.00) (the “ Loss Threshold ”), in which event Seller shall be obligated to indemnify the Buyer Indemnitees for all Buyer Damages over and above the Loss Threshold; and (b) under no circumstances will the aggregate of all Buyer Damages exceed $1,000,000 (“ Seller’s Indemnification Cap ”); provided, however, further, that Seller’s Indemnification Cap shall not apply to any Seller Indemnification Obligation arising out of, relating to or resulting from fraud or intentional misrepresentation of material facts by Seller. Any indemnification hereunder shall be net of amounts recoverable from third parties or insurance.

 

ARTICLE IX

MISCELLANEOUS

 

9.1      Disclaimer of Warranties . EXCEPT AS TO THOSE MATTERS EXPRESSLY COVERED BY THE REPRESENTATIONS AND WARRANTIES IN THIS AGREEMENT, SELLER IS SELLING THE PURCHASED ASSETS (AND THE BUSINESS REPRESENTED THEREBY) ON AN “AS IS, WHERE IS” BASIS AND DISCLAIMS ALL OTHER WARRANTIES, REPRESENTATIONS AND GUARANTEES, WHETHER EXPRESS OR IMPLIED. SELLER MAKES NO IMPLIED REPRESENTATION OR WARRANTY AS TO MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE AND NO OTHER IMPLIED WARRANTIES WHATSOEVER.

 

9.2      Costs and Expenses . Except as otherwise expressly provided herein, each party shall bear its own expenses in connection herewith.

 

9.3      Notices . All notices or other communications permitted or required under this Agreement shall be in writing and shall be sufficiently given if and when hand delivered to the persons set forth below or if sent by documented overnight delivery service or registered or certified mail, postage prepaid, return receipt requested, or by telegram, facsimile, receipt acknowledged, at the address of the party set forth below or to such other person or persons and/or at such other address or addresses as shall be furnished in writing by any party hereto to the others. Any such notice or communication shall be deemed to have been given as of the date received, in the case of personal delivery, or on the date shown on the receipt or confirmation therefore in all other cases.

 

 

Seller:

AOAExcel, Inc.

Attn : President

243 North Lindbergh Boulevard, Floor 1

St. Louis, Missouri 63141

Tel: 314-983-4148

Fax: 314-991-4101

 

 
10

 

   

With copies to:

Michael A. Stokes, Esq.

General Counsel

American Optometric Association

243 North Lindbergh Boulevard, Floor 1

St. Louis, Missouri 63141

Tel: 314- 983-4105

Fax: 314-991-4101

   
  and
   
 

Edward A. Chod, Esq.

Greensfelder, Hemker & Gale, P.C.

10 S. Broadway, Suite 2000

St. Louis, Missouri 63102

Tel: 314-516-2618

Fax: 314-421-0831

   
Buyer: 

OccuLogix LLC
9980 Huennekens Street

Suite 100

San Diego, California 92122

Attn: Elias Vamvakas

Tel: 858-455-6006

Fax: 858-812-0540

   
With copies to: TearLab Corporation

9980 Huennekens Street

Suite 100

San Diego, California 92122

Attn: Elias Vamvakas

Tel: 858-455-6006

Fax: 858-812-0540                

   
  and
   
 

Martin J. Waters, Esq.

Wilson Sonsini Goodrich & Rosati PC

12235 El Camino Real

Suite 200

San Diego, California 92130

Tel: 858-350-2308

Fax: 858-350-2399

 

9.4      Assignment and Benefit .

 

(a)     No party shall assign any of its respective rights or obligations hereunder without the prior written consent of the other parties, other than to an affiliate; provided, however , no assignment shall relieve the assignor of any of its obligations hereunder.

 

 
11

 

   

(b)      Except as provided in Sections 8.2 and 8.3 with respect to indemnification of Indemnified Persons hereunder, nothing in this Agreement shall confer any right, benefit, priority or interest upon any person or entity other than the parties hereto and their respective successors and permitted assigns. Notwithstanding the foregoing, AOA members shall have rights and benefits and are third party beneficiaries with respect to the Additional Consideration provided for in Section 2.1(b) of this Agreement.

 

9.5      Amendment, Modification and Waiver . The parties may amend or modify this Agreement in any respect. Any such amendment or modification shall be in writing and signed by all parties. The waiver by a party of any breach of any provision of this Agreement shall not constitute or operate as a waiver of any other breach of such provision or of any other provision hereof, nor shall any failure to enforce any provision hereof operate as a waiver of such provision or of any other provision hereof.

 

9.6      Governing Law . This Agreement is made pursuant to, and shall be construed and enforced in accordance with, the laws of the State of Missouri without giving effect to otherwise applicable principles of conflicts of law. Seller and Buyer hereby submit to the jurisdiction of the state courts of the County of St. Louis, Missouri and to the United States Federal Court of the Eastern District of Missouri, and each party agrees that such courts shall be the proper and exclusive venue for any dispute arising out of this Agreement.

 

9.7      Section Headings and Defined Terms . The section headings contained herein are for reference purposes only and shall not in any way affect the meaning and interpretation of this Agreement. The terms defined herein and in any agreement executed in connection herewith include the plural as well as the singular and the singular as well as the plural, and the use of masculine pronouns shall include the feminine and neuter. Except as otherwise indicated, all agreements defined herein refer to the same as from time to time amended or supplemented or the terms thereof waived or modified in accordance herewith and therewith.

 

9.8      Severability . If any provision of this Agreement is found or declared to be invalid or unenforceable by any court or other competent authority having jurisdiction, such finding or declaration shall not invalidate any other provision hereof, and this Agreement shall thereafter continue in full force and effect except that such invalid or unenforceable provision, and (if necessary) other provisions hereof, shall be reformed by a court of competent jurisdiction so as to effect insofar as is practicable, the intention of the parties as set forth in this Agreement, provided that if such court is unable or unwilling to effect such reformation, the invalid or unenforceable provision shall be deemed deleted to the same extent as if it had never existed .

 

9.9      Counterparts; Facsimile or Electronic Transmission . This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original and all of which together shall constitute one and the same Agreement. The exchange of copies of this Agreement and of signature pages by facsimile or electronic pdf transmission shall constitute effective execution and delivery of this Agreement as to the parties and may be used in lieu of the original Agreement for all purposes. Signatures of the parties transmitted by facsimile or electronic pdf transmission shall be deemed to be their original signatures for all purposes .

 

9.10      Entire Agreement . This Agreement, together with the schedules, attachments and other documents referred to herein or delivered pursuant hereto, constitute the entire agreement between the parties hereto with respect to the purchase and sale of the Purchased Assets and supersede all prior agreements and understandings, relating to the matters specifically addressed herein and therein.

 

 
12

 

   

9.11      Guaranty . Parent irrevocably, unconditionally and absolutely guaranties to Seller the prompt payment and performance by Buyer of all of its obligations under this Agreement, and/or any other agreement being executed incident hereto. Parent waives any and all defenses, claims, setoffs and discharges with respect to such obligations, except the defense of discharge by payment and performance in full and any defense available to Buyer that is provided for in this Agreement. Parent will not exercise or enforce any right of contribution, reimbursement, recourse, or subrogation as to any such obligations against Buyer until all such obligations have been fully paid and performed. If Seller commences litigation to enforce this Section 9.11 and is the prevailing party as determined by a final order of a court of competent jurisdiction, Parent will pay all reasonable costs incurred by Seller including reasonable attorneys’ fees and expenses, in connection with the enforcement of this Section 9.11.

 

9.12      Certain Definitions . The following terms used in this Agreement shall have the meaning set forth below unless the context otherwise clearly indicates:

 

(a)     “ Buyer’s and Parent’s Knowledge ” means the actual knowledge of Elias Vamvakas obtained in the ordinary course of the performance of his respective duties as officer of the Buyer and Parent.

 

(b)     “ Material ” means (i) with respect to any item, fact, condition or circumstance of a party, that such item, fact, condition or circumstance, individually or in the aggregate with other items, facts, conditions or circumstances affecting such party, would cause an adverse effect of Twenty-Five Thousand ($25,000) Dollars or more to the other party subsequent to the closing of the transactions contemplated by this Agreement or (ii) with respect to any contract or series of related contracts that in the aggregate represents the payment or receipt by any party thereto of Twenty-Five Thousand ($25,000) Dollars or more.

 

(c)     “ Person ” means any individual, partnership, corporation, business trust, joint stock company, trust, unincorporated association, joint venture or other entity of whatever nature.

 

(d)     “ Seller’s Knowledge ” means the actual knowledge, without any independent investigation, of either of Joe E. Ellis or Michael Stokes obtained in the ordinary course of the performance of their respective duties on behalf of Seller .

 

 

 

 

[remainder of this page is intentionally left blank; signatures on following page]

 

 
13

 

 

 

IN WITNESS WHEREOF, each of the parties hereto has duly executed this Agreement as of the date first above written.

   

 

 

SELLER

 

     
 

AOAExcel, Inc.

 

 

 

 

 

 

 

 

 

 

By:

/s/ Joe E. Ellis

 

 

 

Name:   Joe E. Ellis

 

 

 

Title:     Duly Authorized

 

   

 

 

 

BUYER

 

     
  OccuLogix LLC  

 

 

 

 

 

 

 

 

 

By:

/s/ Elias Vamvakas

 

 

 

Name:   Elias Vamvakas

 

 

 

Title:     President, CEO

 

 

 

 

 

 

PARENT

 

     
 

TearLab Corporation

 

 

 

 

 

 

 

 

 

 

By:

/s/ Elias Vamvakas

 

 

 

Name:   Elias Vamvakas

 

 

 

Title:     Chief Executive Officer

 

 

 

 

[Signature Page to Asset Purchase Agreement]

 

 
14

 

 

Attachment A

 

Bill of Sale, Assignment and Assumption Agreement

 

THIS BILL OF SALE AND ASSIGNMENT AND ASSUMPTION AGREEMENT (this “ Agreement ”) is entered into as of this ____ day of March, 2014 by and between AOAExcel, Inc., a Delaware corporation (“ Seller ”), and OccuLogix LLC, a Delaware limited liability company, a wholly-owned subsidiary of TearLab Corporation (“ Buyer ”), pursuant to that certain Asset Purchase Agreement dated as of even date herewith, by and among Seller, Buyer and TearLab Corporation, a Delaware corporation, (the “ Purchase Agreement ”). All capitalized terms used and not otherwise defined herein will have the respective meanings ascribed to such terms in the Purchase Agreement.

 

WHEREAS, pursuant to the Purchase Agreement, Seller has agreed to sell certain assets to Buyer and Buyer has agreed to purchase certain assets from Seller, and Buyer has also agreed to assume certain liabilities of Seller.

 

NOW, THEREFORE, pursuant to the Purchase Agreement and in consideration of the mutual promises contained therein, and for other good and valuable consideration, the receipt and sufficiency of which Seller and Buyer each acknowledge, the parties agree as follows:

 

1.     Seller hereby sells, transfers, assigns and delivers to Buyer, and Buyer hereby purchases from Seller, all of Seller’s right, title and interest in and to the Purchased Assets, free and clear of all encumbrances. The Purchased Assets are being sold “AS IS, WHERE IS” without any representation or warranty of any kind except as otherwise provided in the Purchase Agreement.

 

2.      Seller hereby assigns, transfers and delivers to Buyer, and Buyer hereby assumes and agrees to perform, pay or discharge, when due, all of Seller’s liabilities, obligations and commitments arising out of, resulting from or relating to, any of the Assumed Liabilities. Notwithstanding anything herein to the contrary, Buyer will not assume any liabilities referred to in Section 2.3 of the Purchase Agreement.

 

3.     This Agreement is subject to all of the terms, conditions and limitations set forth in the Purchase Agreement, all of which are incorporated herein by reference. In the event of any conflict or inconsistency between the terms of this Agreement and the terms of the Purchase Agreement, the terms of the Purchase Agreement will prevail. Nothing contained herein will be deemed to alter, modify, expand or diminish the terms of the Purchase Agreement.

 

4.     Buyer and Seller agree, upon reasonable request from time to time by the other party, to execute and deliver all documents and do all other acts which may be reasonably necessary or desirable to further evidence and effectuate the assignment of the Purchased Assets and the assumption of the Assumed Liabilities.

 

5.     This Agreement will be governed by and construed in accordance with the laws of the State of Missouri without giving effect to any law or rule that would cause the laws of any jurisdiction other than the State of Missouri to be applied.

 

6.     This Agreement shall be binding upon and inure solely to the benefit of each party hereto and its respective successors and permitted assigns, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person any rights, interests, benefits or remedies of any nature whatsoever under or by reason of this Agreement.

 

 
15

 

   

7.     Neither this Agreement nor any term hereof may be amended, waived, discharged or terminated, except by a written instrument duly executed on behalf of each party by a duly authorized officer or employee.

 

8.     This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original and all of which together shall constitute one and the same Agreement. The exchange of copies of this Agreement and of signature pages by facsimile or electronic pdf transmission shall constitute effective execution and delivery of this Agreement as to the parties and may be used in lieu of the original Agreement for all purposes. Signatures of the parties transmitted by facsimile or electronic pdf transmission shall be deemed to be their original signatures for all purposes .

 

 

[Remainder of this page is intentionally left blank; Signatures on following page]  

 

 
16

 

 

IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

 

 

 

SELLER

 

     
 

AOAExcel, Inc.

 

 

 

 

 

 

 

 

 

 

By:

/s/ Joe E. Ellis    

 

 

 

Name:   Joe E. Ellis

 

 

 

Title:     Duly Authorized

 

 

 

 

 

BUYER

 

     
 

OccuLogix LLC

 

 

 

 

 

 

 

 

 

 

By:

/s/ Elias Vamvakas

 

 

 

Name:   Elias Vamvakas

 

 

 

Title:     President, CEO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[Signature Page to Bill of Sale, Assignment and Assumption Agreement]

 

 
17

 

 

Schedule 1.1(e)

 

Assigned Contracts*

 

 

1.

The following contracts and agreements with AT&T:

 

 

(a)

Amagine – AOA Portal Hosting & Services Agreement dated April 3, 2012 between Amagine, Inc. and Seller; as the same has been assigned to AT&T.

 

 

(b)

AT&T Master Agreement Amendment #1 (MA Reference No. 20121115-0135), dated December 19, 2012, between AT&T and Seller.

 

 

(c)

AT&T Healthcare Community Online Price Schedule, Document No. 20121115-0138, dated November 15, 2012, between AT&T and Seller.

 

 

(d)

AT&T Healthcare Community Online Pricing Schedule, Document No. 20130717-7008, dated July 17, 2013, between AT&T and Seller; as amended and/or supplemented by that certain AT&T’s Healthcare Community Online Service Description attached thereto.

 

 

(e)

AT&T Healthcare Community Online Statement of Work, Document No. 20130530-3255, dated May 30, 2013, between AT&T and Seller.

 

 

(f)

AT&T Cloud Service – AT&T Medical Image and Information Management Pricing Schedule, Document No. 20130530-3253, dated May 30, 2013, between AT&T and Seller.

 

 

(g)

AT&T Cloud Services – AT&T Medical Image and Information Management Pricing Addendum, Document No. 20131001-6906, dated October 2, 2013, between AT&T and Seller.

 

 

(h)

AT&T Healthcare Community Online Statement of Work Amendment #1, Document No. 20131205-9913, dated December 6, 2013, between AT&T and Seller.

 

 

(i)

AT&T Healthcare Community Online Statement of Work, Document No. 20130717-7013, dated July 17, 2013, between AT&T and Seller.

 

 

(j)

AT&T Healthcare Community Online Pricing Schedule, Document No. 20130530-3250, dated May 30, 2013, between AT&T and Seller; as amended and/or supplemented by that certain AT&T’s Healthcare Community Online Service Description attached thereto.

 

 

(k)

AT&T Healthcare Community Online Statement of Work, Document No. 20121116-0005, dated November 16, 2012, between AT&T and Seller.

 

 

(l)

AT&T Cloud Services AT&T Medical Image and Information Management Pricing Addendum, Document No. 20131205-9909, dated December 6, 2013, between AT&T and Seller.

   

 
18

 

 

2.

End User License Agreement and Sub-License for AcuoMed/Acuostore/ ACOUIHE/AcuoRIS/PACS Synchronizer (ARPA) System dated May 30, 2013, among Acuo Technologies, LLC, AT&T and Seller.

 

3.

End User License Agreement for Calgary Scientific, Inc./Pureweb and Resolution MD dated May 30, 2013, among Calgary Scientific, Inc., AT&T and Seller.

 

4.

Statement of Work dated October 29, 2013 between Cloud Accounting Services for Enterprises, Inc. (CASE) and Seller.

 

5.

Master Subscription Agreement with AppExtremes, Inc. d/b/a Conga, as amended and/or supplemented by Subscription Invoice, Invoice No. 131023-23405 dated November 7, 2013.

 

6.

Verbal agreement (order form/invoice dated October 13, 2013) with DocuSign, Inc.

 

7.

FinancialForce.com Master Subscription Agreement; as amended and/or supplemented by that certain Agreement/Sales Order Form dated October 29, 2013, between Financial Force.com and Seller.

 

8.

Small Center Subscription Agreement dated effective as of July 8, 2013 between Interactive Intelligence CaaS, Inc. and Seller.

 

9.

Small Center Subscription Agreement Addendum dated October 10, 2013 between Interactive Intelligence CaaS, Inc. and Seller.

 

10.

Small Center Subscription Agreement Addendum dated January 15, 2014 between Interactive Intelligence CaaS, Inc. and Seller.

 

11.

Mutual Non-Disclosure Agreement dated June 10, 2013 between Interactive Intelligence CaaS, Inc. and Seller.

 

12.

Independent Contractor Agreement dated July 10, 2013, between Seller and David Jaco.

 

13.

Online Master Subscription Agreement (last updated November 27, 2013) with Sales Force.com; as amended and/or supplemented by that certain Salesforce.com Order Form dated October 4, 2012 between SalesForce.com and Seller.

 

14.

Verbal consulting agreement with Ramsey Solutions.

 

 

*     These contracts are being assigned to the extent that (i) they apply to the Business, (ii) there is any work to be completed or any monies to be paid, and (iii) they are assignable.  

 

 
19

 

 

Schedule 2.2(c)

 

Assumed Liabilities

 

 

1.     Disputed AT&T claim – approximately $29,000 under contract #________ per direction of Barry Baressi.

 

2.     Any liabilities associated with the automated recurrent billing software known as Recurly – https://recurly.com .

 

3.     Any liabilities associated with the Office 365 account to the extent used by Buyer.

 

 
20

 

 

Schedule 3.3

 

Designated Employees

 

 

 

 
21

 

 

Schedule 4.6

 

Material Assets

 

 

1.     AOA and AOAExcel personnel.

 

2.     Cash and liquid assets.

 

3.     Computers, laptops, I-Pads and similar equipment.

 

4.     Off-the-shelf software.

 

5.     Office space.

 

6.     The automated recurrent billing software known as Recurly – https://recurly.com .

 

7.     Office 365 account.

 

 

 22

Exhibit 10.2

 

 

 

TearLab

9980 Huennekens St, Suite 100

San Diego, CA 92121

858 455-6006

Fax 858-812-0540

 

February 28, 2014

 

 

Barry J Barresi, OD, PhD

 

 

Dear Barry:

 

TearLab Corporation (the “Company” or “TearLab”) is pleased to offer you the position of Chief Executive Officer of the Company’s wholly owned subsidiary, OcuHub. Your specific job duties and responsibilities may change from time to time as determined by the Company’s management in its sole discretion. If you decide to join, you will receive an annual salary of $250,000.00. It will be paid semi-monthly in accordance with the Company’s normal payroll procedures and will be subject to the usual, required withholding. Your employment status will be exempt and as an exempt employee, you will not be eligible to receive overtime compensation. Your performance will be subject to an annual review by your supervisor. As an employee, you will also be eligible to participate in the employee benefit plans currently and hereafter maintained by the Company of general applicability to other employees of the Company. Your employee benefits if you choose to participate are effective on the first day. The details of these employee benefits are explained in Exhibit A . You should note that the Company may modify job titles, salaries and benefits from time to time as it deems necessary.

 

If you choose to join our company following the consummation of the transaction contemplated by and among AOAExcel, Inc., OccuLogix LLC, and TearLab (the “Transaction”), there will be one lump sum payment of $35,000.00, less all applicable withholdings, payable within ten (10) business days after the commencement of your employment with the Company. In the event that you voluntarily terminate your employment for any reason whatsoever within the year of your start date, you will be required to repay the full sum back.

 

You will be eligible to receive 25% of your salary as an annual bonus which will be prorated from your date of hire during your first year of employment based on the number of calendar days you are employed. This bonus plan or arrangement has been established by the Company’s Board of Directors in its sole discretion. In no event will any bonus payable to you be paid later than March 15 of the calendar year following the calendar year in which the bonus is earned.

   

 
 

 

 

Also, our company will cover relocation costs up to $15,000. You must be an employee of the Company on the date a relocation expense is incurred and must submit a claim for reimbursement (with appropriate receipts) within thirty (30) days after the date the expense is incurred. The Company will reimburse you within thirty (30) days following your timely submission of a valid claim. You are responsible for reimbursing us the amount paid in relocation costs if you do not work for us at least one full year.

 

The Company is excited about your joining and looks forward to a beneficial and productive relationship. Nevertheless, you should be aware that your employment with the Company is for no specified period and constitutes at-will employment. As a result, you are free to resign at any time, for any reason or for no reason. Similarly, the Company is free to conclude its employment relationship with you at any time, with or without cause, and with or without notice. We request that, in the event of resignation, you give the Company at least two weeks’ notice.

 

The Company reserves the right to conduct background investigations and/or reference checks on all of its potential employees. Your job offer, therefore, is contingent upon a clearance of such a background investigation and/or reference check, if any.

 

For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided to us within three (3) business days of your date of hire, or our employment relationship with you may be terminated.

 

We also ask that, if you have not already done so, you disclose to the Company any and all agreements relating to your prior employment that may affect your eligibility to be employed by the Company or limit the manner in which you may be employed. It is the Company’s understanding that any such agreements will not prevent you from performing the duties of your position and you represent that such is the case. Moreover, you agree that, during the term of your employment with the Company, you will not engage in any other employment, occupation, consulting or other business activity directly related to the business in which the Company is now involved or becomes involved during the term of your employment, nor will you engage in any other activities that conflict with your obligations to the Company. Similarly, you agree not to bring any third party confidential information to the Company, including that of your former employer, and that in performing your duties for the Company you will not in any way utilize any such information.

   

 
 

 

 

As a Company employee, you will be expected to abide by the Company’s rules and standards. As a condition of your employment, you are also required to sign and comply with an At-Will Employment, Confidential Information, Invention Assignment and Arbitration Agreement which requires, among other provisions, the assignment of patent rights to any invention made during your employment at the Company, and non-disclosure of Company proprietary information. In the event of any dispute or claim relating to or arising out of our employment relationship, you and the Company agree that (i) any and all disputes between you and the Company shall be fully and finally resolved by binding arbitration, (ii) you are waiving any and all rights to a jury trial but all court remedies will be available in arbitration, (iii) all disputes shall be resolved by a neutral arbitrator who shall issue a written opinion, (iv) the arbitration shall provide for adequate discovery, and (v) the Company shall pay all the arbitration fees, except an amount equal to the filing fees you would have paid had you filed a complaint in a court of law.

 

This letter is our formal offer of employment and requires your written acceptance. If our offer is acceptable to you, please countersign this letter below and return the signed original or scanned copy to me by 5:00 p.m. Pacific Time on March 3, 2014 . Your employment with TearLab will then begin immediately following the closing of the Transaction. A duplicate original is enclosed for your records. This letter, along with any agreements relating to proprietary rights between you and the Company, sets forth the terms of your employment with the Company and supersedes any prior representations or agreements including, but not limited to, any representations made during your recruitment, interviews or pre-employment negotiations, whether written or oral. This letter, including, but not limited to, its at-will employment provision, may not be modified or amended except by a written agreement signed by the Chief Executive Officer of the Company and you. This offer of employment will terminate if it is not accepted, signed and returned by 5:00 p.m. Pacific Time on March 3, 2014 .

 

[Signature Page Follows]

 

 
 

 

 

We look forward to your favorable reply and to working with you at the Company .

 

 

Sincerely ,  

 

 

 

 

 

/s/ Elias Vamvakas  

 

 

 

Elias Vamvakas  

   
 

Chief Executive Officer

 

Agreed to and accepted:  
       
Signature: /s/ Barry Barresi       
       
Printed Name: Barry Barresi  
       
Date:      

   

 
 

 

 

Exhibit A

 

 

Employee benefits:

 

 

Sick Leave

 

 

Reimbursement of monthly cell phone charges (via Concur)

 

 

Military Leave of Absence

 

 

Pregnancy Disability Leave of Absence

 

 

Unpaid Family School Partnership Leave

 

 

Lactation Break

 

 

Voting Leave

 

 

Jury and Witness Duty Leave

 

 

Bereavement Leave

 

 

Vacation- On an accrual basis per pay period

 

Years Days

Month 0-12

15 days

Month 12-24

16 days

Month 24-36

17 days

Each Additional Year

Increase by 1 day

Maximum Accrual of Vacation hours equivalent to 30 days

 

 

Holidays

 

 

Health Insurance (Co-Pay)

 

 

Vision Insurance (Co-Pay)

 

 

Dental Insurance (Co-Pay)

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 99.1

 

 

 

News Release

For Immediate Release

 

 

TearLab Closes Acquisition of AOA’s OcuHub Technology Platform

 

SAN DIEGO, March 14, 2014 – TearLab Corporation (NASDAQ:TEAR; TSX:TLB) (“TearLab” or the “Company”) today announced the closing of the acquisition of the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association (“AOA”).

 

As of the close of the transaction, the OcuHub purchased assets and business activities will be operated out of a fully-owned subsidiary of TearLab. Barry Barresi, OcuHub’s CEO and former executive director of the AOA, will remain CEO of TearLab’s OcuHub subsidiary. The net purchase was approximately $1.4 million, paid in cash and the Company is in the process of completing the analysis of the accounting treatment of the transaction.

 

OcuHub, powered by AT&T and Covisint, facilitates an effective and efficient shared care model with a single sign-on portal, which simplifies secure connectivity between doctors, patients, institutions and payers. It is a subscription-based service that is HIPAA compliant and eliminates the need for a complex and expensive IT structure. In addition, eye care practices of all sizes will be able to benefit from OcuHub’s cloud-based technology advances and innovations, such as electronic medical records software, image management and storage, practice management tools and marketing programs.

 

“We believe that the OcuHub offering is completely aligned with our corporate mission to partner with the eye care community to deliver innovative technologies that enable doctors to provide the highest quality of care for their patients,” commented Elias Vamvakas, TearLab’s Chief Executive Officer. “We are excited to welcome Barry and his team to the TearLab family and look forward to updating everyone on OcuHub’s progress as we move forward.”

 

About TearLab Corporation

 

TearLab Corporation (www.tearlab.com) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab® Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. Headquartered in San Diego, CA, TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol 'TEAR' and on the Toronto Stock Exchange under the symbol 'TLB'.

 

Forward-Looking Statements

 

This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about TearLab. Examples of forward-looking statements in this press release include, without limitation, statements regarding the future potential of the OcuHub network and the TearLab Osmolarity System and the related impact on our sales, which may not grow as anticipated if the OcuHub network is not accepted by the market, which failure may negatively affect our business and our revenues. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. Many factors may cause our actual results to differ materially from any forward-looking statement, including the factors detailed in our filings with the Securities and Exchange Commission and Canadian securities regulatory authorities, including but not limited to our Annual Report on Form 10-K for the year ended December 31, 2012, filed with the SEC on March 26, 2013, and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, filed with the SEC on November 13, 2013. We do not undertake to update any forward-looking statements.

 

CONTACT:

Stephen Kilmer

(647) 872-4849

skilmer@tearlab.com